Logo image of HLBZ

HELBIZ INC (HLBZ) Stock Fundamental Analysis

NASDAQ:HLBZ - Nasdaq - US42309B2043 - Common Stock - Currency: USD

0.1167  -0.01 (-4.5%)

After market: 0.1077 -0.01 (-7.71%)

Fundamental Rating

1

Taking everything into account, HLBZ scores 1 out of 10 in our fundamental rating. HLBZ was compared to 39 industry peers in the Ground Transportation industry. HLBZ may be in some trouble as it scores bad on both profitability and health. HLBZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HLBZ has reported negative net income.
HLBZ had a negative operating cash flow in the past year.
HLBZ Yearly Net Income VS EBIT VS OCF VS FCFHLBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -20M -40M -60M

1.2 Ratios

HLBZ has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLBZ Yearly ROA, ROE, ROICHLBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 200 -200 400 600 800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HLBZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HLBZ Yearly Profit, Operating, Gross MarginsHLBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

HLBZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HLBZ has less shares outstanding
HLBZ has a better debt/assets ratio than last year.
HLBZ Yearly Shares OutstandingHLBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 10M 20M 30M
HLBZ Yearly Total Debt VS Total AssetsHLBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 10M 20M 30M 40M 50M

2.2 Solvency

HLBZ has an Altman-Z score of -20.43. This is a bad value and indicates that HLBZ is not financially healthy and even has some risk of bankruptcy.
HLBZ's Altman-Z score of -20.43 is on the low side compared to the rest of the industry. HLBZ is outperformed by 95.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -20.43
ROIC/WACCN/A
WACC9.46%
HLBZ Yearly LT Debt VS Equity VS FCFHLBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 -20M -40M

2.3 Liquidity

A Current Ratio of 0.29 indicates that HLBZ may have some problems paying its short term obligations.
The Current ratio of HLBZ (0.29) is worse than 95.00% of its industry peers.
HLBZ has a Quick Ratio of 0.29. This is a bad value and indicates that HLBZ is not financially healthy enough and could expect problems in meeting its short term obligations.
HLBZ has a worse Quick ratio (0.29) than 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
HLBZ Yearly Current Assets VS Current LiabilitesHLBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for HLBZ have decreased strongly by -59.94% in the last year.
The Revenue has grown by 103.67% in the past year. This is a very strong growth!
EPS 1Y (TTM)-59.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.72%
Revenue 1Y (TTM)103.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.84%

3.2 Future

HLBZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.95% yearly.
The Revenue is expected to grow by 130.35% on average over the next years. This is a very strong growth
EPS Next Y34.68%
EPS Next 2Y32.29%
EPS Next 3Y17.85%
EPS Next 5Y9.95%
Revenue Next Year268.18%
Revenue Next 2Y168.59%
Revenue Next 3Y155.76%
Revenue Next 5Y130.35%

3.3 Evolution

HLBZ Yearly Revenue VS EstimatesHLBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
HLBZ Yearly EPS VS EstimatesHLBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HLBZ. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HLBZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HLBZ Price Earnings VS Forward Price EarningsHLBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HLBZ Per share dataHLBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

HLBZ's earnings are expected to grow with 17.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y17.85%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.26%, HLBZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.55, HLBZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, HLBZ's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

HLBZ does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y32.29%
EPS Next 3Y17.85%
HLBZ Yearly Income VS Free CF VS DividendHLBZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 -20M -40M -60M

More info and screens

HELBIZ INC

NASDAQ:HLBZ (3/30/2023, 8:00:02 PM)

After market: 0.1077 -0.01 (-7.71%)

0.1167

-0.01 (-4.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)11-14 2022-11-14/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.75%
Ins Owner Change0%
Market Cap34.16M
Analysts85.71
Price Target13.26 (11262.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.66
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.06
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.13%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -20.43
F-Score2
WACC9.46%
ROIC/WACCN/A
Cap/Depr(3y)191.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.72%
EPS Next Y34.68%
EPS Next 2Y32.29%
EPS Next 3Y17.85%
EPS Next 5Y9.95%
Revenue 1Y (TTM)103.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.84%
Revenue Next Year268.18%
Revenue Next 2Y168.59%
Revenue Next 3Y155.76%
Revenue Next 5Y130.35%
EBIT growth 1Y-156.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.08%
EBIT Next 3Y24.37%
EBIT Next 5Y17.05%
FCF growth 1Y-232.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-276.78%
OCF growth 3YN/A
OCF growth 5YN/A